Valuation: Illumina, Inc.

Capitalization 23.3B 19.92B 18.49B 17.34B 32.17B 2,134B 34.45B 212B 83.98B 1,009B 87.37B 85.58B 3,684B P/E ratio 2025 *
33.6x
P/E ratio 2026 * 34.4x
Enterprise value 24.48B 20.93B 19.43B 18.22B 33.81B 2,243B 36.2B 223B 88.25B 1,060B 91.81B 89.93B 3,871B EV / Sales 2025 *
5.71x
EV / Sales 2026 * 5.4x
Free-Float
79.72%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+3.61%
1 week+5.91%
Current month+16.25%
1 month+13.13%
3 months+54.08%
6 months+60.85%
Current year+16.25%
More quotes
1 week 137
Extreme 137
153.11
1 month 130.42
Extreme 130.42
153.11
Current year 130.42
Extreme 130.42
153.11
1 year 68.7
Extreme 68.7
153.11
3 years 68.7
Extreme 68.7
238.55
5 years 68.7
Extreme 68.7
555.77
10 years 68.7
Extreme 68.7
555.77
More quotes
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer - 09/08/2023
Director TitleAgeSince
Director/Board Member 71 29/11/2012
Director/Board Member 69 28/01/2016
Director/Board Member 65 28/07/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+3.61%+5.91%+7.90%-25.40% 23.3B
+2.79%+2.33%+11.04%+7.18% 239B
-0.71%-4.22%-13.31%+103.95% 186B
+3.29%+1.72%-0.84%-11.79% 171B
+0.56%-2.17%-9.12%+101.03% 136B
-2.00%-6.65%-16.26%-9.37% 56.94B
+2.01%+2.45%+21.68%+7.38% 49.41B
+2.90%-4.21%-8.39%-10.36% 39.62B
+2.41%-0.09%+4.64%+10.46% 37.77B
+2.88%-4.92%-7.14%+21.46% 36.94B
Average +1.75%-1.05%-0.98%+19.46% 97.57B
Weighted average by Cap. +1.45%-0.75%-1.34%+33.57%
See all sector performances

Financials

2025 *2026 *
Net sales 4.29B 3.67B 3.4B 3.19B 5.92B 393B 6.34B 39.05B 15.45B 186B 16.08B 15.75B 678B 4.41B 3.77B 3.5B 3.28B 6.09B 404B 6.52B 40.18B 15.9B 191B 16.54B 16.2B 697B
Net income 658M 563M 522M 490M 909M 60.28B 973M 5.99B 2.37B 28.49B 2.47B 2.42B 104B 678M 580M 538M 505M 937M 62.13B 1B 6.18B 2.44B 29.36B 2.54B 2.49B 107B
Net Debt 1.18B 1.01B 939M 881M 1.63B 108B 1.75B 10.78B 4.27B 51.23B 4.44B 4.35B 187B 520M 445M 413M 387M 719M 47.66B 769M 4.74B 1.88B 22.53B 1.95B 1.91B 82.28B
More financial data * Estimated data
Logo Illumina, Inc.
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.
Employees
9,000
More about the company
Date Price Change Volume
21/01/26 152.48 $ +3.61% 2,269,034
20/01/26 147.17 $ +3.90% 2,090,295
16/01/26 141.65 $ -2.51% 1,901,812
15/01/26 145.30 $ +0.92% 1,700,422
14/01/26 143.97 $ -2.05% 2,065,648

Delayed Quote Nasdaq, January 22, 2026 at 12:00 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
152.48USD
Average target price
133.24USD
Spread / Average Target
-12.62%
Consensus

Quarterly revenue - Rate of surprise